| Document Date: 2009-03-31 16:07:19
Open Document File Size: 60,57 KBShare Result on Facebook
Company Amgen / / Event FDA Phase / / Facility Laboratory Tests Patients / American College of Rheumatology / / IndustryTerm healthcare / / MedicalCondition tumor / inflammatory and immunological responses / pneumonia / necrosis / disease / respiratory failure / bacterial pneumonia / Carcinogenesis / chronic obstructive pulmonary disease / rheumatoid arthritis / chronic / cellulitis / neutropenia / diabetes / infectious / erythema / pulmonary fibrosis / Patients With Hepatic Dysfunction / juvenile rheumatoid arthritis / renal disease / hypersensitivity / infection / bone resorption / active rheumatoid arthritis / inflammation / Infections / inflammatory stimuli / asthma / / MedicalTreatment Immunosuppression / Immunizations / vaccination / antibiotic therapy / / MusicGroup Nausea / / Organization World Health Organization / the American College / assessed using the American College / / Person Van De Loo / Van Lent / Package Insert / / Position Physician / Major / representative / General / / Product Kineret / SC / leflunomide / sodium chloride / sulfasalazine / azathioprine / / Technology alpha / Pharmacokinetics / antibodies / recombinant DNA technology / been conducted examining the pharmacokinetics / /
SocialTag |
Label - Anakinra (Kineret), Amgen